Please sign in to follow a disease.

Relapsed / refractory AML

Clinical trials for Relapsed / refractory AML explained in plain language.

Never miss a new study

Get alerted when new Relapsed / refractory AML trials appear

Sign up with your email to follow new studies for Relapsed / refractory AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2

Donor cells take on tough leukemia in new trial

Disease control Not yet recruiting

This study tests a new treatment for acute myeloid leukemia (AML) that has returned or not responded to standard therapy. It uses specially modified immune cells from a healthy donor to attack the cancer. The first part finds the safest dose, and the second part checks how well i…

Matched conditions: RELAPSED / REFRACTORY AML

Phase 1/2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC

Relapsed / refractory AML

Get alerted when new Relapsed / refractory AML trials appear

Donor cells take on tough leukemia in new trial